Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency

OBJECTIVE: On the basis of our previous work with triheptanoin, which provides key substrates to the Krebs cycle in the brain, we wished to assess its therapeutic effect in patients with glucose transporter type 1 deficiency syndrome (GLUT1-DS) who objected to or did not tolerate ketogenic diets. ME...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Neurol Neurosurg Psychiatry
Autori principali: Mochel, Fanny, Hainque, Elodie, Gras, Domitille, Adanyeguh, Isaac M, Caillet, Samantha, Héron, Bénédicte, Roubertie, Agathe, Kaphan, Elsa, Valabregue, Romain, Rinaldi, Daisy, Vuillaumier, Sandrine, Schiffmann, Raphael, Ottolenghi, Chris, Hogrel, Jean-Yves, Servais, Laurent, Roze, Emmanuel
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2016
Soggetti:
Movement Disorders
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4853553/
https://ncbi.nlm.nih.gov/pubmed/26536893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2015-311475
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi